Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02891200 · ClinicalTrials.gov registry record · NA

Impact of a Peer Support Program Amongst COPD Patients and Their Caregivers

A NA study of COPD, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
292
Enrollment target
2
Study locations

NCT02891200: Completed NA study of COPD, sponsored by Johns Hopkins University.

NCT02891200 is a NA study of COPD that has completed, run by Johns Hopkins University. The registered enrollment target is 292 participants, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02891200, a NA study of COPD, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
292 participants
Enrollment target
2
Study locations

Study Summary

The study is to compare the effectiveness of two health communication and dissemination strategies that are designed to engage patients and family caregivers in successfully managing COPD in 'real-world' settings. Both strategies aim to advance patient understanding of COPD, its treatment options, and self-care tasks; support them in coping with the disease; and enable them to adopt a variety of positive behaviors, including adherence to treatment plans, smoking cessation, joining pulmonary rehabilitation programs, and assuming an active, healthy lifestyle. One strategy relies on the healthcare professional (HCP) as the primary communicator about COPD self-management (HCP arm), whereas the other uses a dual approach that involves both healthcare professionals and peer mentors delivering such communication (HCP plus Peer arm). Peer mentors are COPD patients and caregivers who have successfully managed COPD and have received foundational training on peer mentoring. Specifically, the study aims are to : 1) Conduct a randomized controlled trial in which the 'HCP' and 'HCP plus Peer' strategies are tested in 'real-world' healthcare settings; 2) compare the impact of these strategies on patient satisfaction, experience, activation, self- efficacy, self-care behavior, health status, quality of life, use of Emergency Department (ED) and hospital services, and survival; and, 3) compare the impact of these strategies on caregiver satisfaction, experience, self-efficacy, stress, and coping skills.

Primary Outcome

Change in health-related quality of life (HRQoL) at 6 months post-enrollment from baseline. The HRQoL is measured using the St. George Respiratory Questionnaire (SGRQ), a validated instrument that will be administered to participant by a trained research team member. SGRQ measures health-related quality of life among patients with respiratory diseases. It is a 40 items questionnaire grouped into three domains (Symptoms, Activity, and Impacts). The overall summary score is calculated by summing t

Conditions Studied

Interventions

  • OTHER Peer support program
  • OTHER HCP support

Study Locations (2)

Maryland

  • Johns Hopkins Bayview Medical Center - Baltimore
  • Howard County General Hospital - Columbia

Trial Details

FieldValue
Enrollment Target 292 participants
Start Date 2017-04-17
Est. Completion 2019-11-04
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT02891200 record still lists

NCT02891200 is an interventional study that assigns participants to a tested intervention. The registered 292 participants enrollment target is mid-sized for trials with a published cap, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (88% lower).

The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 2 interventions - of which Peer support program is the first listed.

NCT02891200 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02891200 about?

NCT02891200 is a clinical study titled "Impact of a Peer Support Program Amongst COPD Patients and Their Caregivers". The study is to compare the effectiveness of two health communication and dissemination strategies that are designed to engage patients and family caregivers in successfully managing COPD in 'real-world' settings. Both strategies aim to advance patient understanding of COPD, its treatment options, a...

What is the current status of trial NCT02891200?

This trial is currently completed. It is a NA study. The enrollment target is 292 participants. The study started on 2017-04-17. Estimated completion is 2019-11-04.

What conditions does trial NCT02891200 study?

This clinical trial studies the following conditions: COPD.

What interventions are being tested in trial NCT02891200?

The interventions under investigation include: Peer support program (OTHER), HCP support (OTHER).

Who is sponsoring clinical trial NCT02891200?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02891200 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02891200's enrollment target sits among peer trials

292 24th of 85 higher than 62 of 85 other COPD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04429542 · 292 participants · Phase 1

    Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • NCT05406622 · 292 participants · NA

    MOTIV BTK Randomized Controlled Trial

  • NCT05757102 · 292 participants · Phase 3

    A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  • NCT06569667 · 292 participants · NA

    Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02891200, the US trial registry maintained by the National Library of Medicine. NCT02891200 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.